Improving aspirin prophylaxis in a primary care diabetic population

Pharmacotherapy

Volumn 23, Issue 1, 2003, Pages 73-79

  Faragon, John J ^a   Waite, Nancy M ^a   Hobson, Eric H ^a   Seoldo, Nathalie ^b   VanAmburgh, Jenny A ^c   Migden, Hedy ^d  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b INDIAN HEALTH SERVICE   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

^d Altamont Internal Medicine Pediatrics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; PROPHYLAXIS;

EID: 0037229912     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.1.73.31923     Document Type: Article

References (20)

1. National Institutes of Health. Diabetes in America, 2nd ed. Washington, DC: National Institutes of Health, 1995.
2. Stalmer J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-year cardiovascular mortality in men screened in the multiple risk factor intervention trial. Diabetes Care 1993;16:434-44.
3. Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 1999;159:1873-80.
4. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing physicians' health study. N Engl J Med 1989;321:129-35.
5. Early Treatment Diabetic Retinopathy Study Investigators. Aspirin effects on mortality and morbidity in patients with diabetes mellitus. JAMA 1992;268:1292-300.
6. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomized trial. Lancet 1998;351:1755-62.
7. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308:81-106.
8. Colwell JA. Aspirin therapy in diabetes. Diabetes Care 1997;20:1767-71.
9. American Diabetes Association. Clinical practice recommendations. Aspirin therapy in diabetes. Diabetes Care 2002;25(suppl 1):78-9.
10. Rolka DB, Fagot-Campagna A, Venkat Narayan KM. Aspirin use among adults with diabetes. Estimates from the third national health and nutrition examination survey. Diabetes Care 2001;24:197-201.
11. Stafford RS. Aspirin use is low among United States outpatients with coronary artery disease. Circulation 2000;101:1097-101.
12. Chin MH, Auerbach SB, Cook S, et al. Quality of diabetes care in community health centers. Am J Public Health 2000;90:431-4.
13. Schoenfeld ER, Greene JM, Suh Yuh Wu MA, Leske MC. Patterns of adherence to diabetes vision care guidelines. Ophthalmology 2001;108:563-71.
14. Sikka R, Sutton DR, Waters J, Herman WH, Moore W, Aubert RE. Renal assessment practices and the effect of nurse care management of health maintenance organization patients with diabetes. Diabetes Care 1999;21:1-6.
15. Legorreta AP, Pelletier KR, Hasan MM, Leung KW, Peters AL. An intervention for enhancing compliance with screening recommendations for diabetic retinopathy. Diabetes Care 1997;20:520-3.
16. Wagner EH, McGregor M, Grothaus LC, et al. Chronic care clinics for diabetes primary care. Diabetes Care 2001;25:695-700.
17. American Diabetes Association. Clinical practice recommendations. Aspirin therapy in diabetes. Diabetes Care 2000;23(suppl 1):61-2.
18. VanAmburgh JA, Waite NM, Hobson EH, Migden H. Improved influenza vaccination rates in a rural population as a result of a pharmacist-managed immunization campaign. Pharmacotherapy 2001;21:1115-22.
19. Izzo CH, VanAmburgh JA, Waite NM, Hobson EH, Migden H. A pneumococcal vaccine intervention in a high-risk rural population [abstr]. Pharmacotherapy 2000;20:1276.
20. Szilagyi PG, Bordley C, Vann JC, et al. Effect of patient reminder/recall interventions on immunization rates. JAMA 2000;284:1820-7.